Understanding disease modifiers and heterogeneity in Alzheimers disease

The aim of UndoAD is to identify disease modifiers to explain the heterogeneity found in Alzheimer’s disease. This will be achieved by strengthening an already existing partnership between a Columbian Alzheimer’s disease research center and German partners. By establishing a shared database, establishing novel laboratory techniques and launching a common educational and training platform we will be able to better define Alzheimer’s disease subgroups which may turn out to be therapy-relevant.